Skip to main content

Osteoarthrosis

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
Hip ArthroplastyN/A1 trial
Active Trials
NCT02518269Active Not Recruiting360Est. Nov 2030
UCB Pharma
UCB PharmaBelgium - Brussels
1 program
10 mg of Hydrocodone Bitartrate Extended ReleasePHASE_21 trial
Active Trials
NCT02222740Completed37Est. Dec 2002
IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
Chondroitin 4&6 sulfatePHASE_31 trial
Active Trials
NCT00291499Completed163Est. Aug 2010
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
ReCap, Hip resurfacing system, BiometPHASE_41 trial
Active Trials
NCT00116948Completed50Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Merck & Co.ReCap, Hip resurfacing system, Biomet
IBSA Institut BiochimiqueChondroitin 4&6 sulfate
UCB Pharma10 mg of Hydrocodone Bitartrate Extended Release
Zimmer BiometHip Arthroplasty

Clinical Trials (4)

Total enrollment: 610 patients across 4 trials

NCT00116948Merck & Co.ReCap, Hip resurfacing system, Biomet

A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter

Start: Jan 2005Est. completion: Jan 201250 patients
Phase 4Completed
NCT00291499IBSA Institut BiochimiqueChondroitin 4&6 sulfate

Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand

Start: Jun 2005Est. completion: Aug 2010163 patients
Phase 3Completed
NCT02222740UCB Pharma10 mg of Hydrocodone Bitartrate Extended Release

A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain

Start: Sep 2002Est. completion: Dec 200237 patients
Phase 2Completed
NCT02518269Zimmer BiometHip Arthroplasty

A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty

Start: May 2015Est. completion: Nov 2030360 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.